echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New targetforthed for pancreatic cancer, study finds The king of cancer, Cersei, shivering!

    New targetforthed for pancreatic cancer, study finds The king of cancer, Cersei, shivering!

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Photo Source: FASEB J For this experiment, researchers first produced a protein-modifying spectrum of drug-resistant and non-resistant cells from pancreatic cancer cell linesBy comparing these maps, they found changes in specific protein modifications associated with drug-resistant cellsThere is PML in drug-resistant cells and is known for its involvement in an aggressive form of leukemiaUsing cultured cells, the researchers found that a change in PML modification known as ubiquitinization was also involved in pancreatic cancer cells' resistance to chemotherapy therapyUsing a patient-sourced xenotransplant model, the researchers found that higher levels of PML expression and higher levels of PML ubiquity had higher survival ratesInstead, the study showed that patients with low PML expression and PML low ubiquitinhadhad had a worse survival rate because their tumors showed resistance to chemotherapy treatment"These findings can improve the prognosis of pancreatic cancer patients in a relatively short period of time," said DrPhilippe Soubeyran, a researcher at the Maasai Cancer Research Centre (CRCM) at the French National Institute of Health and Medical Research"In the long run, we may be able to improve the treatment of pancreatic cancer by restoring the drug's efficacy against drug-resistant tumors"It's an interesting finding that the post-translation modification of this protein is so decisive, " said DrThoru Pederson, editor-in-chief of theFASEB magazineThis not only resets the therapeutic dimension, but may also indicate similar cancer protein events in other malignant tumors"
    References: Philippe Soubeyran et alPML hyposumoying is responsible for the ford of the cancerThe FASEB Journal DOI:
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.